fiercebiotech.com
Medium Opportunity · 60/100
26y2000-03-26Domain Age
829.2K+14%Monthly Visits
Direct 45%United States 73%Primary Channel
2Competitors

Product Identity

About

|

Categoryhealth/biotechnology_and_pharmaceuticals

Product Identity · Insight

Operating for 26 years with no public revenue or community data — likely a traditional business or niche market product.

Growth Profile

Monthly Visits

829,198

13.9% vs last month

Bounce Rate

59.4%

Pages / Visit

1.6

Avg. Session

1m 1s

Domain Age

26.4 years

#81,760Global Rank
#29,371Country Rank (840)
#17Category Rank · Biotechnology_and_Pharmaceuticals
Traffic Trend
13.9%

Growth Profile · Insight

Traffic is growing (+14%) but bounce rate is elevated (59%) — new visitors may be arriving from low-intent channels or encountering landing page mismatch.

Acquisition Engine

Traffic Sources
Organic Search
31.7%
Direct
44.3%
Social
4.8%
Referral
11.2%
Paid
0.0%
Email
7.2%
Gen AI
0.8%
Geographic Distribution
DomainShareBar
🇺🇸United StatesUS
73.3%
🇬🇧United KingdomGB
3.9%
🇰🇷South KoreaKR
3.6%
🇨🇳ChinaCN
3.5%
🇨🇦CanadaCA
1.3%
Top 3 countries account for 80.7% of traffic — high geographic concentration
Top Keywords
Keyword
lilly69.0K$4.01$1.7K
biotech47.6K$1.68$630
chai discovery25.1K$4.25$860
fierce biotech5.5K$4.23$6.1K
genentech layoffs1.8K$0.00$1.2K

Acquisition Engine · Insight

Brand-driven growth (45% direct traffic) alongside 5 ranking keywords — dual acquisition engines reduce channel dependency.

How does fiercebiotech.com actually grow?

This page shows the surface. A Growth Teardown reverse-engineers the full playbook — which keywords drive signups, where backlinks come from, which channels convert, and what you can replicate in your own product.

Competitive Landscape

lilly.com favicon
lilly.com

lilly.com

🔗 2 keyword overlap

Lilly is a medicine company that puts health above all. Learn about our medicines, view condition support, find care, and much more.

5.2M/mo-7%May 1991

Shares 2 keywords including "eli lilly"

medtechdive.com favicon
medtechdive.com

medtechdive.com

🔗 2 keyword overlap

The stroke treatment could contribute about $100 million in incremental revenue over time to Boston Scientific, the buyer of Penumbra, one analyst said.

105.4K/mo+3%Mar 2018

Shares 2 keywords including "whoop"

Competitive Landscape · Insight

Facing significant traffic gap vs lilly.com (6.3x), but keyword overlap is only 2 — likely serving different market segments despite surface-level competition.

Report based on data from July 2026

See a sample report